Translations:Dyslipidemia/22/en

From Azupedia
Revision as of 17:52, 13 April 2024 by FuzzyBot (talk | contribs) (Importing a new version from external source)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

PCSK9 inhibitors

PCSK9 inhibitors are monoclonal antibodies that target an important protein in the degradation of LDL called proprotein convertase substilisin/kexin type 9 (PCSK9). These agents reduce LDL-C, increase HDL-C, decrease triglycerides, and decrease lipoprotein(a). The FOURNIER and ODYSSEY trials showed that these agents also reduced the risk of cardiovascular events.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Dyslipidemia/22/en&oldid=138782"